01 November 2005
Clinical Spectrum and Critical Care Management of Posterior Reversible Encephalopathy Syndrome (PRES).Pasquale Striano, Salvatore Striano, Fabio Tortora, Edoardo De Robertis, Daniela Palumbo, Andrea Elefante, Giuseppe Servillo
Med Sci Monit 2005; 11(11): CR549-553 :: ID: 430371
Background: Posterior Reversible Encephalopathy (PRES) is characterizedby acute-onset headache, altered mental status, cortical blindness and seizures, with parietal-occipitalinvolvement. We report all cases of PRES diagnosed in our intensive care unit during the last 4 years,and evaluate their outcome in terms of the different medical treatments used. Even if usually reversible,PRES can sometimes result in death or irreversible neurological deficit, such as chronic epilepsy. Material/Methods:From January 2001 to January 2005, we identified 8 female patients with PRES. All patients underwentbasal and follow-up brain MRI. Patients referred to Epilepsy Center (about 3000 patients) were reviewedin order to identify subjects with a clinical history of PRES. These latter were clinically re-evaluatedand underwent video-EEG, MRI study and neuropsychological testing. Results: Of the 8 patients, 5 hadhypertensive encephalopathy during pregnancy; 2 had eclampsia during the postpartum period; 1 patientwith chronic renal failure developed symptoms after immunosuppressive treatment. In all patients but1, neurological and radiological abnormalities resolved after appropriate treatment. In addition, wefound 2 patients with temporal lobe epilepsy subsequent to a previous PRES. MRI revealed cortical-subcorticalmalacia in the parietal-occipital regions. Conclusions: The widespread use of MRI technology has madePRES familiar to many clinicians. Although PRES is reversible when treatment is instituted, delayed diagnosisand therapy can result in chronic neurological sequelae. The relationship between hypertensive encephalopathyand chronic epilepsy needs to be confirmed by longitudinal studies. Normalization of blood pressure andtreatment of seizures deserves particular attention.
Keywords: Brain Diseases - therapy, Brain - pathology, Blindness, Cortical - diagnosis, Electroencephalography, Epilepsy - therapy, Headache - therapy, Hypertensive Encephalopathy - therapy, Intensive Care, Magnetic Resonance Imaging, Mental Disorders - therapy, Seizures - therapy, Syndrome
01 December 2021 : EditorialEditorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
Med Sci Monit 2021; 27:e935624
03 December 2021 : Laboratory ResearchInfluenza and Influenza-Like Respiratory Virus Infections in Children During the 2019/20 Influenza Season a...
Med Sci Monit In Press; DOI: 10.12659/MSM.934862
08 November 2021 : Database AnalysisVirtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Cor...
Med Sci Monit In Press; DOI: 10.12659/MSM.934102
01 November 2021 : EditorialEditorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems Duri...
Med Sci Monit 2022; 28:e935299
06 Dec 2021 : Animal ResearchAstragalus Flavone Induces Proliferation and Differentiation of Neural Stem Cells in a Cerebral Infarction ...
Med Sci Monit In Press; DOI: 10.12659/MSM.933830
06 Dec 2021 : Clinical ResearchAlteration of Serum Metabolites in Women of Reproductive Age with Chronic Constipation
Med Sci Monit In Press; DOI: 10.12659/MSM.934117
06 Dec 2021 : Clinical ResearchBody Composition Changes and Related Factors in Patients with Ulcerative Colitis: A Retrospective Single-Ce...
Med Sci Monit In Press; DOI: 10.12659/MSM.933942
Most Viewed Current Articles
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700